As IGFBP2 and VCAM1 have been described above, measuring LDH has traditionally been used as an indicator of myocardial damage or necrosis and has been found to be elevated in patients suffering from valve heart disease, heart failure, and coronary heart disease (48). The gene discussed is IGFBP2; the disease is heart failure.